Analyst Ratings for Aurinia Pharmaceuticals (AUPH)
AUPH Rating Summary
AUPH Price Target Summary
- Highest: $21.00 (Jefferies)
- Lowest: $16.00 (Leerink)
- Average: $18.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$18.50 (+15.3%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
Avg. $ Target:
$18.50 (+15.3%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 71%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/20/2026 | Bloom Burton & Co. | David Martin | Upgrade | Buy (1) (Hold (3)) |
21.00 (N/A) |
16.17 (16.05) |
-0.74% | Details |
| 12/3/2025 | Leerink | Joseph Schwartz | Downgrade | Market Perform (Outperform) |
16.00 (N/A) |
15.91 (16.05) |
0.88% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
